TIGERMED 03347Hong Kong Stock Exchange

45.0401.08%( +0.480 )
Closed: Oct 12 · Delayed · Hong Kong Stock Exchange
TIGERMED (03347) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-08-07
Industry
CRO/CDMO
Fiscal Year End
Dec 31
ISIN
CNE1000040M1
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

CRO/CDMO 0.65%
14 stocks in this industry
Down 7 Up 6
Industry RankingsValue (HKD)Rank
Revenue (Last FY)8.01B6/14
Net Profit (Last FY)1.04B6/14
ROE (Last FY)4.24%8/14

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
叶小平 Executive Director
曹晓春 Executive Director
闻增玉 Executive Director
吴灏 Executive Director
袁华刚 Independent Non-Executive Director
刘毓文 Independent Non-Executive Director
萧耀熙 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-02.

About this page

This page shows TIGERMED (03347) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.